These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28818537)

  • 1. Predicting Grade and Stage at Cystoscopy in Newly Presenting Bladder Cancers-a Prospective Double-Blind Clinical Study.
    Mariappan P; Lavin V; Phua CQ; Khan SAA; Donat R; Smith G
    Urology; 2017 Nov; 109():134-139. PubMed ID: 28818537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can urologists accurately stage and grade urothelial bladder cancer by assessing endoscopic photographs?
    Dekalo S; Matzkin H; Mabjeesh NJ
    J Telemed Telecare; 2018 Oct; 24(9):603-607. PubMed ID: 28920525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Good quality white-light transurethral resection of bladder tumours (GQ-WLTURBT) with experienced surgeons performing complete resections and obtaining detrusor muscle reduces early recurrence in new non-muscle-invasive bladder cancer: validation across time and place and recommendation for benchmarking.
    Mariappan P; Finney SM; Head E; Somani BK; Zachou A; Smith G; Mishriki SF; N'Dow J; Grigor KM;
    BJU Int; 2012 Jun; 109(11):1666-73. PubMed ID: 22044434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of histological stage based on cystoscopic appearances of newly diagnosed bladder tumours.
    During VA; Sole GM; Jha AK; Anderson JA; Bryan RT
    Ann R Coll Surg Engl; 2016 Nov; 98(8):547-551. PubMed ID: 27502337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system.
    Nishiyama N; Kitamura H; Maeda T; Takahashi S; Masumori N; Hasegawa T; Tsukamoto T
    Jpn J Clin Oncol; 2013 Nov; 43(11):1124-31. PubMed ID: 23980236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder.
    Herr HW; Donat SM; Dalbagni G
    J Urol; 2002 Sep; 168(3):978-80. PubMed ID: 12187203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can re-cTURBT be useful in pT1HG disease as a risk indicator of recurrence and progression? A single centre experience.
    Giulianelli R; Gentile BC; Mirabile G; Albanesi L; Tariciotti P; Rizzo G; Buscarini M; Vermiglio M
    Arch Ital Urol Androl; 2017 Dec; 89(4):272-276. PubMed ID: 29473376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical significance of a second transurethral resection for T1 high-grade bladder cancer: Results of a prospective study.
    Shim JS; Choi H; Noh TI; Tae JH; Yoon SG; Kang SH; Bae JH; Park HS; Park JY
    Korean J Urol; 2015 Jun; 56(6):429-34. PubMed ID: 26078839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II multi-center trial of optical coherence tomography as an adjunct to white light cystoscopy for intravesical real time imaging and staging of bladder cancer.
    Sung HH; Scherr DS; Slaton J; Liu H; Feeny KL; Lingley-Papadopoulos C; Gearheart J; Zara JM; Lerner SP
    Urol Oncol; 2021 Jul; 39(7):434.e23-434.e29. PubMed ID: 33934964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.
    Koie T; Ohyama C; Hosogoe S; Yamamoto H; Imai A; Hatakeyama S; Yoneyama T; Hashimoto Y; Yoneyama T; Tobisawa Y; Mori K
    Int Urol Nephrol; 2015 Sep; 47(9):1509-14. PubMed ID: 26149637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacing cystoscopy by urine markers in the follow-up of patients with low-risk non-muscle-invasive bladder cancer?-An International Bladder Cancer Network project.
    Schmitz-Dräger C; Bonberg N; Pesch B; Todenhöfer T; Sahin S; Behrens T; Brüning T; Schmitz-Dräger BJ
    Urol Oncol; 2016 Oct; 34(10):452-9. PubMed ID: 27381893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.
    Gendy R; Delprado W; Brenner P; Brooks A; Coombes G; Cozzi P; Nash P; Patel MI
    BJU Int; 2016 Apr; 117 Suppl 4():54-9. PubMed ID: 26486968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical rationale and safety of restaging transurethral resection in indication-stratified patients with high-risk non-muscle-invasive bladder cancer.
    Zapała P; Dybowski B; Poletajew S; Białek Ł; Niewczas A; Radziszewski P
    World J Surg Oncol; 2018 Jan; 16(1):6. PubMed ID: 29334958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-life Experience: Early Recurrence With Hexvix Photodynamic Diagnosis-assisted Transurethral Resection of Bladder Tumour vs Good-quality White Light TURBT in New Non-muscle-invasive Bladder Cancer.
    Mariappan P; Rai B; El-Mokadem I; Anderson CH; Lee H; Stewart S; Donat R
    Urology; 2015 Aug; 86(2):327-31. PubMed ID: 26142924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [T1 high-grade bladder cancer - value of second operation with prognostuic parameters of first operation: analysis of 167 cases].
    Lazica DA; Böttcher S; Degener S; von Rundstedt FC; Brandt AS; Roth S; Störkel S; Mathers MJ
    Aktuelle Urol; 2013 Mar; 44(2):124-8. PubMed ID: 23580383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
    Chang WC; Chang YH; Pan CC
    Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of surgeon's perception during transurethral resection of bladder tumors: can we trust in our eyes and experience to predict grade and staging?
    Vale L; Sousa J; Abreu-Mendes P; Vale P; Dias N; Dinis P; Antunes-Lopes T; Silva J
    Porto Biomed J; 2022; 7(4):e179. PubMed ID: 36186116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of cystoscopy in predicting histologic features of bladder lesions.
    Mitropoulos D; Kiroudi-Voulgari A; Nikolopoulos P; Manousakas T; Zervas A
    J Endourol; 2005 Sep; 19(7):861-4. PubMed ID: 16190845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage T1 bladder cancer: grade is the primary determinant for risk of muscle invasion.
    Kaubisch S; Lum BL; Reese J; Freiha F; Torti FM
    J Urol; 1991 Jul; 146(1):28-31. PubMed ID: 2056599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.